Smoking Cessation, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2023-03 · 21 (3) · 297-322
DOI: 10.6004/jnccn.2023.0013 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2023-03. Verfasst von Peter G Shields und 30 weiteren Autor:innen. Beteiligte Einrichtung: The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute. Hauptthemen laut MEDLINE: Smoking Cessation, Tobacco Products, Neoplasms. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 206 Literaturangaben.
Abstract (Originalsprache)
Although the harmful effects of smoking after a cancer diagnosis have been clearly demonstrated, many patients continue to smoke cigarettes during treatment and beyond. The NCCN Guidelines for Smoking Cessation emphasize the importance of smoking cessation in all patients with cancer and seek to establish evidence-based recommendations tailored to the unique needs and concerns of patients with cancer. The recommendations contained herein describe interventions for cessation of all combustible tobacco products (eg, cigarettes, cigars, hookah), including smokeless tobacco products. However, recommendations are based on studies of cigarette smoking. The NCCN Smoking Cessation Panel recommends that treatment plans for all patients with cancer who smoke include the following 3 tenets that should be done concurrently: (1) evidence-based motivational strategies and behavior therapy (counseling), which can be brief; (2) evidence-based pharmacotherapy; and (3) close follow-up with retreatment as needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.
- Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.
- University of Michigan Rogel Cancer Center.
- UT Southwestern Simmons Comprehensive Cancer Center.
- The University of Texas MD Anderson Cancer Center.
- Duke Cancer Institute.
Zitieren
APA
Shields, P. G., Bierut, L., Arenberg, D., Balis, D., Cinciripini, P. M., Davis, J., Edmondson, D., Feliciano, J., Hitsman, B., Hudmon, K. S., Jaklitsch, M. T., Leone, F. T., Ling, P., McCarthy, D. E., Ong, M. K., Park, E. R., Prochaska, J., Sandoval, A. J., Sheffer, C. E., …, & Darlow, S. (2023). Smoking Cessation, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 21(3), 297-322. https://doi.org/10.6004/jnccn.2023.0013
Vancouver
Shields PG, Bierut L, Arenberg D, Balis D, Cinciripini PM, Davis J, et al. Smoking Cessation, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2023;21(3):297-322. doi:10.6004/jnccn.2023.0013
BibTeX
@article{Shields2023,
author = {Shields, Peter G and Bierut, Laura and Arenberg, Douglas and Balis, David and Cinciripini, Paul M and Davis, James and Edmondson, Donna and Feliciano, Joy and Hitsman, Brian and Hudmon, Karen S and Jaklitsch, Michael T and Leone, Frank T and Ling, Pamela and McCarthy, Danielle E and Ong, Michael K and Park, Elyse R and Prochaska, Judith and Sandoval, Argelia J and Sheffer, Christine E and Spencer, Sharon and Studts, Jamie L and Tanvetyanon, Tawee and Tindle, Hilary A and Tong, Elisa and Triplette, Matthew and Urbanic, James and Videtic, Gregory and Warner, David and Whitlock, C Will and McCullough, Beth and Darlow, Susan},
title = {Smoking Cessation, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2023},
volume = {21},
number = {3},
pages = {297--322},
doi = {10.6004/jnccn.2023.0013}
}
EUVIMED